Related Experiment Video
Updated: Jul 16, 2026

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis
Published on: April 17, 2017
[Hepatitis C viral infection and depression]
Gabriella Lengyel1, Zsuzsa Aszalós, Zsolt Tulassay
1Semmelweis Egyetem, Altalános Orvostudományi Kar II. Belgyógyászati Klinika Budapest. lengyel@bel2.sote.hu
Insights
Chronic hepatitis C (HCV) infection significantly increases depression risk. This review explores HCV
Area of Science:
- Hepatology
- Neuropsychiatry
- Virology
Background:
- Chronic hepatitis C virus (HCV) infection affects 170 million globally.
- Depression occurs in 58% of patients with chronic HCV, significantly higher than in the general population.
- HCV is linked to central nervous system alterations and neuropathogenesis.
Purpose of the Study:
- To review the etiology of depression in liver diseases, focusing on HCV.
- To examine the neuropathogenic effects of HCV on the central nervous system.
- To discuss the role of alpha-interferon treatment in HCV-related depression.
Main Methods:
- Literature review of scientific evidence on HCV, CNS alterations, and depression.
- Analysis of the biological basis, development, and consequences of interferon-induced depression.
- Review of diagnostic protocols and psychiatric drug therapy for depression in chronic liver disease.
Main Results:
- Hepatitis C virus infection causes central nervous system alterations.
- Depression is a known side effect of alpha-interferon therapy for HCV.
- Interferon treatment cessation in depressed patients may lead to fatal liver disease outcomes.
Conclusions:
- A collaborative approach between internists and psychiatrists is crucial for managing depression in chronic HCV patients.
- Careful consideration is needed regarding interferon treatment for HCV patients with depression.
- Balancing the risks of depression and the benefits of interferon therapy is essential for patient outcomes.
Abstract:
About 170 million individuals can be found with chronic hepatitis C viral infection all over the world. The occurrence of depression is more frequent among the persons than in the healthy population, this depression can be found in 58 per cent of patients with chronic hepatitis C. On the basis of the literature the authors review the aetiology of depression in liver diseases, examining the neuropathogenic effect of HCV. They demonstrate the scientific results which are evidences of hepatitis C viral infection for the alterations in the central nerve system. The depression is one of the side effects of the alpha-interferon treatment used in the therapy of HCV. The authors demonstrate the biological basis, development, consequences of depression produced by interferon and they give a review of the protocol in the diagnostic procedure of a patient with depression. They summarize the steps of psychiatric drug therapy in chronic liver diseases. That is also important whether the chronic HCV infected patient with depression can be treated with interferon. The loss of interferon treatment can lead to the fatal outcome of liver disease. In order to have the correct decision a collaboration between internist and psychiatric specialist is necessary.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Depression: Overview
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Cirrhosis II: Pathophysiology

